Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
21.43
+0.56 (2.68%)
At close: Oct 3, 2025, 4:00 PM EDT
21.40
-0.03 (-0.14%)
After-hours: Oct 3, 2025, 7:41 PM EDT
Summit Therapeutics Employees
Summit Therapeutics had 159 employees as of December 31, 2024. The number of employees increased by 54 or 51.43% compared to the previous year.
Employees
159
Change (1Y)
54
Growth (1Y)
51.43%
Revenue / Employee
n/a
Profits / Employee
-$4,692,314
Market Cap
15.92B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 159 | 54 | 51.43% |
Dec 31, 2023 | 105 | 28 | 36.36% |
Dec 31, 2022 | 77 | -33 | -30.00% |
Dec 31, 2021 | 110 | 29 | 35.80% |
Dec 31, 2020 | 81 | 11 | 15.71% |
Dec 31, 2019 | 70 | 9 | 14.75% |
Dec 31, 2018 | 61 | -15 | -19.74% |
Dec 31, 2017 | 76 | 36 | 90.00% |
Dec 31, 2016 | 40 | 3 | 8.11% |
Dec 31, 2015 | 37 | 14 | 60.87% |
Dec 31, 2014 | 23 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SMMT News
- 11 days ago - Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 11 days ago - HARMONi-6, Featuring Ivonescimab Combined with Chemotherapy vs. Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in China, to be Showcased in Presidential Symposium at ESMO 2025 - Business Wire
- 13 days ago - Ten Bull Market 10-Baggers - Seeking Alpha
- 17 days ago - Summit Therapeutics: Buy the Next Dip Amid Clinical Breakthrough Potential - FXEmpire
- 19 days ago - Summit Therapeutics Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 25 days ago - CORRECTION -- Summit Therapeutics Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 26 days ago - Top 3 Health Care Stocks You'll Regret Missing In Q3 - Benzinga
- 27 days ago - Summit Therapeutics (SMMT) WCLC Update Call (Transcript) - Seeking Alpha